TRINOMAB
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

TRINOMAB Trademark

Serial Number: 79350028 • Registration: 7470062

TRINOMAB is a trademark filed by Zhuhai Trinomab Pharmaceutical Co., Ltd. on July 12, 2022. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Zhuhai Trinomab Pharmaceutical Co., Ltd. (9 trademarks)

Rm.110, 1/F., Plant Building 6,

Entity Type: 99

Trademark Details

Filing Date

July 12, 2022

Registration Date

August 13, 2024

Published for Opposition

May 28, 2024

Goods & Services

Scientific research; technological research in the field of pharmaceuticals; technological research in the fields of genetics, genetic engineering, molecular biology and cellular immunology; conducting technical project studies, namely, conducting scientific feasibility studies; scientific laboratory services; research and development of new products for others; chemical analysis; chemical research; biological research; scientific research in the nature of conducting clinical trials for others; chemistry services in the nature of chemist services; chemistry services, namely, consultation, research and advice; none of the above related to the treatment or prevention of cardiovascular diseases

Hospital services; medical assistance; nursing, medical; medical, physical rehabilitation and physical therapy services; alternative medicine services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; blood collection services, namely, collection and preservation of human blood; performing diagnosis of diseases; collection and preservation of human blood; genetic testing for medical purposes; behavioral analysis for medical purposes; rental of medical instruments and apparatus; stem cell therapy services; veterinary assistance; all of the foregoing featuring monoclonal antibodies, and none of the above related to the treatment or prevention of cardiovascular diseases

Retail store services and wholesale distributorship services featuring veterinary pharmaceutical preparations; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale distributorship services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services and wholesale distributorship services featuring pharmaceutical preparations; retail and wholesale store services featuring pharmaceutical preparations; all of the foregoing featuring monoclonal antibodies, and none of the above related to the treatment or prevention of cardiovascular diseases

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 24, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 24, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 24, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 24, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 24, 2025 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 29, 2025 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Feb 1, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Feb 1, 2025 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 13, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 13, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 13, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Jun 11, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 28, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 28, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 15, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 15, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 8, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 24, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 24, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 24, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 24, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 24, 2024 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 11, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 21, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 21, 2024 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 11, 2023 GNFN
FINAL REFUSAL E-MAILED
Oct 11, 2023 GNFR
FINAL REFUSAL WRITTEN
Oct 11, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 30, 2023 TROA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 22, 2023 ADCH
REFUSAL PROCESSED BY IB
Jul 22, 2023 RFNT
ATTORNEY REVIEW COMPLETED
Jun 30, 2023 ATRV
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 28, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jun 28, 2023 RFRR
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Jun 27, 2023 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Jun 10, 2023 LIMG
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 29, 2023 RFCR
NON-FINAL ACTION WRITTEN
Apr 28, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 26, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 23, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 19, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 16, 2022 REPR